Artivion director granted 7,576 restricted shares

ARTIVION, INC. director Thomas F. Ackerman received an equity grant of 7,576 shares of common stock on May 18, 2026, at no cash cost, classified as a grant, award, or other acquisition under the company’s plan.

Rhea-AI Filing Summary

ARTIVION, INC. director Thomas F. Ackerman received an equity grant of 7,576 shares of common stock on May 18, 2026, at no cash cost, classified as a grant, award, or other acquisition under the company’s plan. These restricted shares vest on May 18, 2027, pursuant to the Equity and Cash Incentive Plan. Following this award, Ackerman directly holds 157,472 shares of Artivion common stock.

Insider Trade Summary

Grant/Award: 7,576 shares

Grant/Award 1 txn

Insider ACKERMAN THOMAS F

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,576	$0.00	$0.00

Holdings After Transaction: Common Stock — 157,472 shares (Direct)

Footnotes (1)

1. F1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Key Figures

Shares granted: 7,576 shares Grant price: $0.00 per share Shares held after: 157,472 shares +1 more

4 metrics

Shares granted 7,576 shares Restricted stock award on May 18, 2026

Grant price $0.00 per share Equity grant classified as compensation, not market purchase

Shares held after 157,472 shares Total direct holdings following the reported grant

Vesting date May 18, 2027 RSA Grant vests per Equity and Cash Incentive Plan

Key Terms

RSA Grant, Equity and Cash Incentive Plan, Grant, award, or other acquisition

3 terms

RSA Grant financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Equity and Cash Incentive Plan financial

"RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan."

Grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Artivion (AORT) report for Thomas F. Ackerman?

Artivion reported that director Thomas F. Ackerman received an equity grant of 7,576 shares of common stock. The award was recorded as a grant or other acquisition at no cash price per share under the company’s incentive plan.

When do Thomas F. Ackerman’s new Artivion (AORT) shares vest?

The 7,576-share restricted stock award granted to Thomas F. Ackerman vests on May 18, 2027. Vesting is governed by the terms of Artivion’s Equity and Cash Incentive Plan, which sets the schedule and conditions for this compensation-related grant.

How many Artivion (AORT) shares does Thomas F. Ackerman hold after this grant?

After receiving the 7,576-share grant, Thomas F. Ackerman directly holds 157,472 shares of Artivion common stock. This figure reflects his position following the reported award and is disclosed as his direct ownership in the Form 4 filing.

Was Thomas F. Ackerman’s Artivion (AORT) transaction an open-market buy or sell?

The transaction was not an open-market buy or sell. It is classified as a grant, award, or other acquisition of 7,576 shares at a price of $0.00 per share, representing stock-based compensation rather than a market trade.

Under what plan was Thomas F. Ackerman’s Artivion (AORT) stock award granted?

The restricted stock award was granted under Artivion’s Equity and Cash Incentive Plan. The footnote states that the RSA Grant vests on May 18, 2027, pursuant to this plan, which governs the company’s equity and cash incentive compensation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/20/2026 - 08:26 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ACKERMAN THOMAS F

(Last) (First) (Middle)

ARTIVION INC

1655 ROBERTS BLVD NW

(Street)

KENNESAW GEORGIA 30144

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
ARTIVION, INC. [ AORT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/18/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/18/2026		A		7,576(1)	A	$0	157,472	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. RSA Grant vests on May 18, 2027, pursuant to the terms of the Equity and Cash Incentive Plan.

Remarks:

	/s/ Thomas F. Ackerman	05/20/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)